SPTX (Seaport Therapeutics) Beneish M-Score


SPTX Seaport Therapeutics Inc SPTX
11 GF Score
Price $21.43
! 1 Warning Sign
View Full Analysis

What is Seaport Therapeutics Beneish M-Score?

Seaport Therapeutics does not have enough data to calculate Beneish M-Score.

Seaport Therapeutics Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Seaport Therapeutics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seaport Therapeutics Beneish M-Score Chart

Seaport Therapeutics Annual Data
Trend Dec24 Dec25
Beneish M-Score
0.00 0.00

Seaport Therapeutics Semi-Annual Data
Dec24 Dec25
Beneish M-Score 0.00 0.00

SPTX vs LXRX, DRTS, MGTX: Beneish M-Score Comparison

For the Biotechnology subindustry, Seaport Therapeutics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Seaport Therapeutics Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Seaport Therapeutics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Seaport Therapeutics's Beneish M-Score falls into.


SPTX
11GF Score
Seaport Therapeutics Inc SPTX
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seaport Therapeutics Business Description

Address 101 Seaport Boulevard, Floor 12, Boston, MA, USA, 02210
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
11GF Score

Get the complete analysis for SPTX

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.43
Price